The sensitivity was 40% when considering records which only used inhaled selective beta-2-adrenoreceptor agonists (step1), while the sensitivity of asthma diagnosis in records with systemic drugs other than adrenergics for obstructive airway diseases was 73%. The gene discussed is ADRB2; the disease is asthma.